Wearing defocus spectacles daily significantly slows myopia progression and axial elongation in myopic school children aged 8 to 13, according to a two-year double-blind randomized clinical trial in which 160 Chinese myopic children in Hong Kong participated. Following the trial, which began in 2014, myopia progression in children wearing defocus lenses slowed in average by 59% and axial elongation reduced in average by 60%. In 21.5 % of the children the myopia progression halted completely.1 The findings provide strong evidence that defocus lenses are effective in reducing myopia progression.
In 2012, HOYA Corporation and The Hong Kong Polytechnic University launched a cooperation with the focus on developing a new myopia control lens which is capable of preventing myopia from worsening or slowing down its progression.
Following years of academic studies, product design and clinical research, HOYA Corporation and The Hong Kong Polytechnic University developed a revolutionary spectacle lens, based on a Defocus Incorporated Multiple Segments Technology or “D.I.M.S. Technology”, which just successfully won the Grand Prize, Grand Award and Gold Medal at the 46th International Exhibition of Inventions of Geneva in April 2018.
The lens, which has a smooth surface and looks almost identical to a regular lens was presented on the 6 March at a symposium in Shanghai which was organized by Hoya. A second successful symposium for key opinion leaders, “Symposium of Defocus Theory and Clinical Results in Myopia Control”, was held at Hong Kong Hyatt Regency Hotel on 25 April, organized by Hoya Lens HK Ltd. and the Global Marketing team.
These events were attended by more than 40 key opinion leaders and the D.I.M.S. technology was very well received.
MyoSmart lenses will be launched in Hong Kong and China in the summer of 2018. A broader, global launch is slated to begin in 2019/2020.